Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PLUS THERAPEUTICS, INC. Director's Dealing 2012

Jan 4, 2012

34301_dirs_2012-01-04_0a30bdcd-96b6-4219-96b3-3e3efd529e34.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2012-01-01

Reporting Person: RICKEY DAVID (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-01-01 Restricted Stock Award (Common Stock) A 10000 Acquired 10000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-01-01 Non-Qualified Stock Opiton $2.2 A 15000 Acquired 2022-01-01 Common Stock (15000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 88559 Indirect
Common Stock 34909 Indirect
Common Stock 146101 Indirect

Footnotes

F1: These securities are owned by the Dave Rickey and Daughters Foundation.

F2: These securities are owned by David M Rickey, Trustee FBO The Rickey Annunity Trust.

F3: These securities are owned by Dave Rickey, TTEE FBO the David Rickey Trust

F4: The Restricted Stock Award vests in full on December 31, 2012, subject to the terms of the Company's 2004 Equity Incentive Plan.

F5: The stock options vest 1/24th each month from date of grant, subject to the terms of the 2004 Equity Incentive Plan.